Last Updated: May 1, 2026

Claims for Patent: 6,432,657

✉ Email this page to a colleague

Summary for Patent: 6,432,657

Title:	Method for determining coagulation parameters
Abstract:	A method for determining coagulation parameters which is safe, convenient, applicable to existing automated analyzers and reliable is disclosed. The said method for the determination utilizes an antibody against the E region of fibrinogen, fibrinogen degradation product D dimer or the like, and is enable to determine the coagulation parameter in fibrin coagulation system accompanied by limited degradation of fibrinogen with thrombin without clotting.
Inventor(s):	Masayoshi Kikuchi, Shin Watanabe, Yoshimichi Yoshimura
Assignee:	A&T Corp , Tokuyama Corp
Application Number:	US09/463,364

Details for Patent 6,432,657

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Revo Biologics, Inc.	ATRYN	antithrombin (recombinant)	For Injection	125284	February 06, 2009	⤷ Start Trial	2018-07-22
Revo Biologics, Inc.	ATRYN	antithrombin (recombinant)	For Injection	125284	April 11, 2014	⤷ Start Trial	2018-07-22
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.